Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2003
09/30/2003US6627202 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
09/30/2003US6627199 Isolation, identification and characterization of tmst2, a novel member of the TNF-receptor supergene family
09/30/2003US6627198 Therapy, prevention tuberculosis infections
09/30/2003US6627195 Binding agents to CD23
09/30/2003US6627190 Telomerase resistance; anticancer agents
09/30/2003US6627189 Supressing expression of human p21 K-ras oncogene
09/30/2003US6627187 Containing an amino acid as a stabilizer; long term storage stability
09/30/2003US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF)
09/30/2003US6627000 UV irradiation of air handlers and other apparatus
09/30/2003CA2262465C Neuritin, a neurogene
09/30/2003CA2168382C Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine
09/30/2003CA2141439C Method for highly purifying human serum albumin
09/30/2003CA2133759C Evaluation and treatment of patients with progressive immunosuppression
09/30/2003CA1341440C Cdna coding for carcinoembryonic antigen
09/28/2003CA2379661A1 Paracellular drug delivery system
09/25/2003WO2003079025A2 Methods for the identification of compounds useful for the suppression of chronic neuropathic pain and compositions thereof
09/25/2003WO2003079022A1 Ffluorescent reagent for selectively detecting double-stranded nucleic acid contianing fluorescent dye group and intercalate group
09/25/2003WO2003078651A2 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits
09/25/2003WO2003078648A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis
09/25/2003WO2003078641A1 Engineered baculoviruses and their use
09/25/2003WO2003078637A2 Optimizing glycan processing in plants
09/25/2003WO2003078636A1 Transdifferentiation of cells and tissues
09/25/2003WO2003078635A1 Gene participating in acetic acid tolerance, acetic acid bacterium bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium
09/25/2003WO2003078633A1 POLYPEPTIDES BINDING TO HUMAN SYNTAXIN 1a
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
09/25/2003WO2003078631A1 Novel genes
09/25/2003WO2003078630A1 INHIBITION OF THE β3 SUBUNIT OF L-TYPE CA2+ CHANNELS
09/25/2003WO2003078614A2 Gntiii (udp-n-acethylglucosamine:beta-d mannoside beta (1,4)-n-acethylglucosaminy ltransferase iii) expression in plants
09/25/2003WO2003078602A2 Methods of expressing non-endogenous g protein coupled receptors in cells
09/25/2003WO2003078598A2 Methods for using bag expression as a cell differentiation agent and marker
09/25/2003WO2003078584A2 Identifying peptide modifications
09/25/2003WO2003078580A2 Imprinting in plants to control gene expression
09/25/2003WO2003078578A2 Modulation of the immune response through the manipulation of arginine levels
09/25/2003WO2003078573A2 Toll-like receptor 11
09/25/2003WO2003078572A2 Therapeutic polypeptides, nucleic acids encoding same and methods of use
09/25/2003WO2003078568A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
09/25/2003WO2003078566A2 Dna sequences of major secreted proteins from the ciliate tetrahymena and use thereof
09/25/2003WO2003078470A1 Fusion peptide grafted with tat peptide to human type-i collagen derived peptide, its preparation method, and cosmetic composition for anti-aging comprising the same
09/25/2003WO2003078467A1 Enhancement of iron chelation therapy
09/25/2003WO2003078466A1 Novel g protein-coupled recepotrs and genes thereof
09/25/2003WO2003078465A1 The use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
09/25/2003WO2003078464A2 Arrays of cytosolic accessory proteins immobilized on a surface and pertinent methods
09/25/2003WO2003078463A1 Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy
09/25/2003WO2003078462A2 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner
09/25/2003WO2003078461A1 Preparation of g-csf stoichiometrically conjugated with biocompatible polymers at cystein residue
09/25/2003WO2003078460A1 Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
09/25/2003WO2003078458A2 Tap-70, a novel marker for epithelial tumors
09/25/2003WO2003078457A1 MUTEINS OF THE C5a ANAPHYLATOXIN, NUCLEIC ACID MOLECULES ENCODING SUCH MUTEINS, AND PHARMACEUTICAL USES OF MUTEINS OF THE C5a ANAPHYLATOXIN
09/25/2003WO2003078456A2 Human diabetes-mediating proteins
09/25/2003WO2003078455A2 Virus like particle from papillomavirus and their use in vaccine
09/25/2003WO2003078453A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
09/25/2003WO2003077998A1 Use of asc-1 inhibitors to treat neurological and psychiatric disorders
09/25/2003WO2003077942A2 Virus-like particles of human papillomavirus
09/25/2003WO2003077939A1 Treatment of metabolic disorders with a tnf receptor family member (fradj and/or cryptic) agonists or antagonists
09/25/2003WO2003077931A1 Transcription factor modulators and uses thereof
09/25/2003WO2003077875A2 Proteins associated with growth, differentiation, and death
09/25/2003WO2003077872A2 Cell surface tropomyosin as a target of angiogenesis inhibition
09/25/2003WO2003077870A2 New strains of mycoplasma hyorhinis as causative agents for autoimmune disease
09/25/2003WO2003077863A2 Method for overexpression of zwitterionic polysaccharides
09/25/2003WO2003077859A2 Method of inducing an enhanced immune response against hiv
09/25/2003WO2003077843A2 Methods for purifying selected cea family member proteins
09/25/2003WO2003077838A2 Hiv-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and immunogens
09/25/2003WO2003077836A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/25/2003WO2003077835A2 Sodium dodecyl sulfate compositions for inactivating prions
09/25/2003WO2003077831A2 Compositions and methods for treating mdma-induced toxicity
09/25/2003WO2003059954A3 Method for specifically immobilizing mediator molecules on substrate surfaces
09/25/2003WO2003057240A3 Treatment and diagnosis of af4-dependant diseases
09/25/2003WO2003046001A3 Protein biopolymer markers predictive of insulin resistance
09/25/2003WO2003044197A9 Huntington’s disease gene transcriptional factors
09/25/2003WO2003042402A3 Agents that modulate immune cell activation and methods of use thereof
09/25/2003WO2003042246A3 Inhibitors of the notch signalling pathway for use in the treatment of cancer
09/25/2003WO2003042245B1 Growth hormone variations in humans and their uses
09/25/2003WO2003040368A3 Pharmaceutical compositions of marine sponge microciona prolifera
09/25/2003WO2003040313A3 Il-21 antagonists
09/25/2003WO2003040295A3 Ion channel
09/25/2003WO2003038724A9 Methods and apparatus for protein sequence analysis
09/25/2003WO2003038041A3 Il-4 mutein proteins, antibodies, compositions, methods and uses
09/25/2003WO2003037925A3 Precursor silk feedstock for forming filaments
09/25/2003WO2003035879A3 Promoters to control cell differentiation
09/25/2003WO2003035682A3 Peptides and protins binding to glu-pro motidfs, therapeutical compositions containing them and their applications
09/25/2003WO2003033655A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
09/25/2003WO2003031470A3 Dna-expression construct for treatment of infections with leishmaniasis
09/25/2003WO2003016343A3 USE OF αCP1, αCP2, AND HUR FOR MODULATING GENE EXPRESSION AND INDUCING ANGIOGENESIS
09/25/2003WO2003014156A3 NEUREGULIN-β ISOFORMS ASSOCIATED WITH NEURONAL PROCESSES
09/25/2003WO2003011331A3 Materials and methods relating to improved vaccination strategies
09/25/2003WO2003008454A3 Glycoprotein vi fusion proteins
09/25/2003WO2003006047A3 Methods for reducing immunogenicity of polypeptides
09/25/2003WO2003004627A3 Novel human hepatoma lines, methods for obtaining same and uses thereof
09/25/2003WO2003003988A3 Peptides which modulate blood coagulation and methods of use thereof
09/25/2003WO2002100827A9 Method for increasing the survival of dopamine secreting cells
09/25/2003WO2002100324A3 Compositions and methods for the repair and construction of bone and other tissue
09/25/2003WO2002099116A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/25/2003WO2002097059A9 Chromosome-based platforms
09/25/2003WO2002095076A3 Modified polypeptides having protease-resistance and/or protease-sensitivity
09/25/2003WO2002094850A3 Haplotypes of the gnrh2 gene
09/25/2003WO2002092635A3 Immunologic compositions and methods for studying and treating cancers expressing frizzled antigens
09/25/2003WO2002092628A3 Plasmodium falciparum antigens and vaccine and diagnostic uses thereof
09/25/2003WO2002083850A8 Vascular endothelial growth factor 2
09/25/2003WO2002077277B1 Dna markers for assessing seed purity and a method of using dna sequences for assessing seed purity
09/25/2003WO2002077205A3 Culture medium for enhanced heterologous protein expression
1 ... 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 ... 2916